Prepregnancy obesity and the racial disparity in infant mortality

Lara S Lemon1,2,3, Ashley I Naimi1, Barbara Abrams4

  • 1Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pennsylvania, USA.

Insights

Prepregnancy obesity contributes to the Black-White disparity in stillbirth and infant mortality. Addressing obesity could reduce these adverse birth outcomes for Black women.

Area of Science:

  • Reproductive Health
  • Perinatal Epidemiology
  • Public Health

Background:

  • Significant racial disparities exist in stillbirth and infant mortality rates in the United States.
  • Non-Hispanic Black women experience disproportionately higher rates of these adverse outcomes compared to non-Hispanic White women.

Purpose of the Study:

  • To quantify the extent to which prepregnancy obesity explains the Black-White disparity in stillbirth and infant mortality.
  • To assess the impact of prepregnancy obesity on racial differences in adverse pregnancy outcomes.

Main Methods:

  • A population-based study utilized linked birth and infant death certificates in Pennsylvania from 2003-2011 and fetal death certificates from 2006-2011.
  • Included singleton pregnancies of non-Hispanic White and non-Hispanic Black women.
  • Inverse probability weighted regression analysis was employed to estimate the role of prepregnancy obesity.

Main Results:

  • Non-Hispanic Black women had higher rates of obesity, stillbirth, and infant death compared to non-Hispanic White women.
  • Removing the contribution of prepregnancy obesity reduced the risk difference for stillbirth and infant death between the two racial groups.
  • Prepregnancy obesity accounted for a notable proportion of excess infant deaths and stillbirths among non-Hispanic Black women.

Conclusions:

  • Prepregnancy obesity is a significant, though not sole, contributor to the Black-White disparity in stillbirth and infant mortality.
  • Interventions targeting prepregnancy obesity may help mitigate racial disparities in adverse perinatal outcomes.
  • Reducing prepregnancy obesity among Black women could lead to a decrease in excess infant deaths and stillbirths.
Abstract

Related Concept Videos

Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
7.3K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.1K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
325
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
342
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
260